Stock·NYSE·Financial Services
The Bank of New York Mellon Corporation (BK)
- Market cap
- $97.53B
- P/E
- 17.02
- Dividend yield
- 1.49%
- Street target
- $144.50median of 16 analysts
- 52-week range
- $103.11 $165.84
The short version
Where BK stands today, in four lines, and what CleaRank Financial AI makes of it.
BK at a glance
The Bank of New York Mellon Corporation (BK): Hold, 55/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($137.94 and $154.83).
- Earnings BK beat estimates in 6 of its last 6 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $10.9M and made no open-market purchases over the last 18 months.
- Valuation P/E of 17.0 against 16.5 for the Financial Services sector: broadly in line with peers (+3%).
Figures as of October 16, 2026.
CleaRank Financial AI
The Bank of New York Mellon Corporation (BK) is currently trading at $142.09, below its 50-day simple moving average of $154.83, indicating near-term weakness.
Despite this, the stock remains above its 200-day SMA of $137.94, suggesting a longer-term uptrend is still intact. The company's financial health is strong, with a strong profit margin of 28.72% and a very low debt-to-equity ratio of 0.02, significantly outperforming sector averages in these areas. However, insider activity shows a moderate sell signal, with $10.9 million in net sales versus no purchases, which warrants attention. Wall Street analysts maintain a 'Buy' consensus with a median price target of $144.50, implying a modest 1.7% upside from the current price. The company has a history of beating earnings estimates, with recent quarters showing positive surprises. Revenue growth is projected at 7.00% for the current year and 4.00% for the next, reflecting steady expansion. The stock's price-to-earnings ratio of 17.02 is in line with the sector average of 16.5, and its price-to-sales ratio of 4.54 is slightly above the sector median of 3.8. This valuation, combined with insider selling, tempers the bullish outlook from analysts.
Only on CleaRank
Figures we compute ourselves from BK's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $142.09 is 8.2% below the 50-day simple moving average of $154.83.Price above its 200-day average ›
The price is 3.0% above the 200-day simple moving average of $137.94.50-day average above the 200-day ›
The 50-day average ($154.83) is 12.2% above the 200-day average ($137.94), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 62% of its 52-week range, between $103.11 and $165.84.
BK share price
Pick a period: each tab shows how far BK has moved over it, to the last close.
Today's trading
Where BK sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 17.02 is 3.1% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 4.54 is 19.4% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $5.7B on revenue of $20.8B, a net margin of 27.6%.Beat estimates in most recent reports ›
BK beat the EPS estimate in 6 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 1.49%, or $2.12 a share a year.
Key statistics
The headline figures for BK.
As of October 16, 2026, BK trades at $142.09, with a market value of $97.53B, a P/E ratio of 17.02 and a dividend yield of 1.49%.
What the numbers say
CleaRank Financial AI's reading of BK's valuation, growth and risks.
The Bank of New York Mellon Corporation (BK) presents a mixed fundamental picture, with a P/E ratio of 17.02 that is slightly above the sector median of 16.5, while its price-to-sales ratio of 4.54 exceeds the sector average of 3.8.
The company demonstrates strong operational efficiency with an operating margin of 37.65% and a net profit margin of 28.72%, both significantly higher than sector averages. Its return on equity stands at a healthy 13.47%, aligning with the sector median of 13.8. Balance sheet strength is a key positive, evidenced by a minimal debt-to-equity ratio of 0.02, far below the sector average. This financial stability provides a solid foundation. However, the moderate insider selling signal, with over $10.9 million in net sales, introduces a note of caution regarding management's short-term confidence. While fundamentals are generally sound, the current valuation and insider activity suggest that the stock may be fairly priced, with limited immediate upside potential.
BK against the Financial Services sector
How BK compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (3% difference), suggesting fair market pricing relative to industry standards.
Return vs KBE: Since May 5, 2025, BK has gained 72.9% against a gain of 21.5% for KBE.
Performance against KBE
BK and the Financial Services sector fund over the same days.
Revenue and earnings
How much BK sells, and how much of it becomes profit.
Revenue growth: Revenue grew 8.2% in FY2025 to $19.8B, from $18.3B a year earlier.
Profit margin: The net margin was 28.3% in FY2025, up from 24.9% the year before.
Profitable: BK earned $5.6B in FY2025.
Earnings reality check
Did BK beat what analysts expected, and how did the stock react?
Earnings record: BK beat the analyst estimate in 6 of the last 6 quarters.
Market reaction: The stock fell in the first session after 2 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 16, 2025after close | $1.77 | $1.91 | +7.91% | -0.69% | -0.04% |
| Jul 15, 2025after close | $1.76 | $1.94 | +10.23% | +0.35% | +3.93% |
| Apr 11, 2025after close | $1.49 | $1.58 | +6.04% | -0.19% | -4.67% |
| Jan 15, 2025after close | $1.57 | $1.72 | +9.55% | +0.26% | +3.28% |
| Oct 11, 2024after close | $1.42 | $1.52 | +7.04% | +3.18% | +3.40% |
| Jul 12, 2024after close | $1.43 | $1.51 | +5.59% | +2.77% | +3.91% |
Reports after October 16, 2025 are not yet in our data.
As of October 16, 2026, BK has beaten the analyst EPS estimate in 6 of its last 6 reported quarters and fell in the first trading session after 2 of those beats; its most recent report in our data, on October 16, 2025, came in 7.91% above the estimate and the stock moved -0.69% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 36.3, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 36.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of BK
The score, the reasoning behind it, and what could move the price next.
The Bank of New York Mellon Corporation (BK) exhibits bearish momentum as indicated by its 14-day RSI of 36.3, which is below the 70 overbought and 30 oversold thresholds.
The stock is trading below both its 20-day EMA at $145.90 and its 50-day SMA at $154.83, signaling near-term downward pressure and suggesting these averages are acting as resistance. The MACD is negative at -4.11, further reinforcing the bearish short-term trend. Key support is identified at the 200-day SMA of $137.94, a level the stock has recently traded above. Resistance is now expected around the 50-day SMA and the 20-day EMA. Volume on the latest trading day was 6.99 million, significantly higher than the average of 3.85 million, indicating increased investor interest, though the price action suggests selling pressure is currently dominant. The current technical setup suggests a cautious approach, with potential for further downside if support at the 200-day SMA fails.
Consistent Earnings Beats ›
The Bank of New York Mellon Corporation (BK) has a history of exceeding analyst EPS estimates, demonstrating operational resilience and effective management, which could support future stock price appreciation.
Source: Earnings ReportsStrong Balance Sheet and Profitability ›
BK's very low debt-to-equity ratio (0.02) and high profit margins (28.72%) provide a strong financial foundation, enabling it to weather economic downturns and potentially return more capital to shareholders.
Source: Company Financials
Moderate Insider Selling Signal ›
Insiders have sold a net $10.9 million worth of BK stock, indicating a potential lack of strong short-term conviction from management, which could weigh on investor sentiment.
Source: Insider TransactionsBearish Technical Momentum ›
The stock is trading below its 50-day SMA and 20-day EMA, with a bearish RSI reading, suggesting potential for further price declines in the near term.
Source: Technical Analysis
- The Bank of New York Mellon Corporation (BK) shows moderate insider selling, with over $10.9 million in net sales, which investors should monitor closely for any signs of accelerated divestment.
- With the 14-day RSI at 36.25, the stock is in bearish territory, suggesting caution for short-term traders until momentum shifts positively above the 50-day SMA.
- Given the current technical setup, consider position sizing carefully and potentially waiting for a confirmed break above the 50-day SMA before increasing exposure.
Technical indicators
Momentum and trend for BK, from its daily closes.
As of October 16, 2026, with BK at $142.09, its 14-day RSI is 36.3 (showing bearish momentum without being oversold), its 50-day simple moving average is $154.83 and its 200-day is $137.94.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What BK moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, BK's 1-year correlation of daily returns is +0.62 with S&P 500 (SPY), +0.52 with Nasdaq 100 (QQQ), +0.27 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
9 of 16 analysts rate it a buy or strong buy, 6 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $144.50 is 1.7% above the price.More buy ratings than three months ago ›
9 of 16 rate it a buy now, against 10 of 17 three months ago.
BK Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 11, 2026 | JP Morgan | Maintains | Overweight |
| Apr 17, 2026 | Barclays | Maintains | Overweight |
| Apr 17, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Apr 17, 2026 | RBC Capital | Maintains | Sector Perform |
| Apr 17, 2026 | Truist Securities | Maintains | Buy |
| Apr 17, 2026 | Evercore ISI Group | Maintains | In-Line |
As of October 16, 2026, 16 Wall Street analysts cover BK: 9 rate it a buy or strong buy, 6 a hold and 1 a sell or strong sell. Their 12-month price targets range from $120.00 to $156.00, with a median of $144.50, 1.7% above the price of $142.09.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BK trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BK's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BK tends to move, against the market and on its own.
The long record
BK's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.19% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 46.7%, from May 2018 to March 2020, regained by August 2021.Most 1-year holds ended higher ›
65% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $46,392, against $42,525 in the S&P 500 (SPY).
BK Drawdowns & Recovery
As of October 16, 2026, BK's worst peak-to-trough fall over the last 10 years with dividends reinvested was -46.7% (May 2018 to March 2020); it regained that peak by August 2021, 17 months after the low, and 65% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BK in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BK beat the S&P 500 over this period: $46,392 against $42,525.
A $10,000 investment in BK in October 2016 would be worth about $46,392 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BK, and which have not.
Strongest month, November: an average of +6.93%, up in 10 of 10 years.
Weakest month, March: an average of -4.35%, up in 3 of 10 years.
This month, October: has averaged +1.68%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BK's strongest calendar month has been November (average +6.93%, up in 10 of 10 years) and its weakest March (average -4.35%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BK, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BK today could grow to about $23,460 by 2036 in the base case, with a 90th-percentile outcome near $70,100 and a 10th-percentile outcome around $7,852. The simulation models price only; at today's 1.49% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
BK Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $200 for BK by 2030 in the base case, from $142 today (1.4x over 4 years). The 10th-percentile path ends near $100. These are outcomes of a Monte Carlo simulation run on BK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $109 | $155 | $219 | |
| 2028 | $103 | $169 | $275 | |
| 2029 | $101 | $184 | $334 | |
| 2030 | $100 | $200 | $399 | |
| 2031 | $100 | $218 | $472 |
Method: a lognormal simulation of BK's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
BK insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought BK shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, BK insiders reported 6 open-market sales worth $10.9M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 17, 2026 | John Kevin Mccarthy
General Counsel
|
Sell | 30.0K | $4.1M |
| Apr 17, 2026 | Alejandro Perez
Officer
|
Sell | 12.5K | $1.7M |
| Apr 17, 2026 | Kurtis R Kurimsky
Officer
|
Sell | 5.3K | $719.5K |
| Apr 17, 2026 | Shannon Marie Hobbs
Officer
|
Sell | 297 | $40.7K |
| Apr 17, 2026 | Alejandro Perez
Officer
|
Grant | 1.0K | - |
| Apr 1, 2026 | Joseph J Echevarria
Director
|
Grant | 743 | $90.0K |
| Apr 1, 2026 | Jeffrey A. Goldstein
Director
|
Grant | 340 | $41.3K |
| Apr 1, 2026 | Ralph Izzo
Director
|
Grant | 227 | $27.5K |
| Apr 1, 2026 | Sandra O'Connor
Director
|
Grant | 227 | $27.5K |
| Apr 1, 2026 | Elizabeth E Robinson
Director
|
Grant | 87 | $10.6K |
| Feb 23, 2026 | John Kevin Mccarthy
General Counsel
|
Grant | 52.5K | - |
| Feb 23, 2026 | Dermot William Mcdonogh
Chief Financial Officer
|
Grant | 56.8K | - |
| Feb 23, 2026 | Robin A. Vince
Chief Executive Officer
|
Grant | 183.8K | - |
| Feb 2, 2026 | Rajashree Datta
Officer
|
Grant | 21.3K | - |
| Feb 2, 2026 | Joseph J Echevarria
Director
|
Grant | 688 | $83.7K |
| Feb 2, 2026 | Jeffrey A. Goldstein
Director
|
Grant | 339 | $41.2K |
| Feb 2, 2026 | Shannon Marie Hobbs
Officer
|
Grant | 9.5K | - |
| Feb 2, 2026 | Ralph Izzo
Director
|
Grant | 328 | $40.0K |
| Feb 2, 2026 | Jayee Koffey
Officer
|
Grant | 11.5K | - |
| Feb 2, 2026 | Kurtis R Kurimsky
Officer
|
Grant | 7.0K | - |
| Feb 2, 2026 | John Kevin Mccarthy
General Counsel
|
Grant | 16.7K | - |
| Feb 2, 2026 | Dermot William Mcdonogh
Chief Financial Officer
|
Grant | 37.7K | - |
| Feb 2, 2026 | Jose Minaya
Officer
|
Grant | 35.7K | - |
| Feb 2, 2026 | Sandra O'Connor
Director
|
Grant | 226 | $27.5K |
| Feb 2, 2026 | Elizabeth E Robinson
Director
|
Grant | 87 | $10.6K |
| Feb 2, 2026 | Robin A. Vince
Chief Executive Officer
|
Grant | 78.2K | - |
| Dec 9, 2025 | Robin A. Vince
Chief Executive Officer
|
Grant | 215.6K | - |
| Nov 6, 2025 | Jayee Koffey
Officer
|
Grant | 925 | - |
| Oct 1, 2025 | Joseph J Echevarria
Director
|
Grant | 783 | $83.8K |
| Oct 1, 2025 | Jeffrey A. Goldstein
Director
|
Grant | 386 | $41.3K |
| Oct 1, 2025 | Ralph Izzo
Director
|
Grant | 374 | $40.0K |
| Oct 1, 2025 | Sandra O'Connor
Director
|
Grant | 257 | $27.5K |
| Oct 1, 2025 | Elizabeth E Robinson
Director
|
Grant | 99 | $10.6K |
| Jul 22, 2025 | John Kevin Mccarthy
General Counsel
|
Sell | 20.0K | $2.0M |
| Jul 1, 2025 | Joseph J Echevarria
Director
|
Grant | 923 | $83.8K |
| Jul 1, 2025 | Jeffrey A. Goldstein
Director
|
Grant | 455 | $41.3K |
| Jul 1, 2025 | Ralph Izzo
Director
|
Grant | 441 | $40.0K |
| Jul 1, 2025 | Sandra O'Connor
Director
|
Grant | 303 | $27.5K |
| Jul 1, 2025 | Elizabeth E Robinson
Director
|
Grant | 117 | $10.6K |
| Apr 29, 2025 | John Kevin Mccarthy
General Counsel
|
Sell | 30.0K | $2.4M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.